QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NASDAQ:EPZM

Epizyme Earnings Date, Estimates & History

$9.26
-0.29 (-3.04 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.17
Now: $9.26
$9.69
50-Day Range
$9.59
MA: $11.08
$12.25
52-Week Range
$9.17
Now: $9.26
$23.61
Volume1.14 million shs
Average Volume856,213 shs
Market Capitalization$942.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.76

Earnings

Epizyme (NASDAQ:EPZM) Earnings Information

Epizyme last announced its earnings data on February 22nd, 2021. The biopharmaceutical company reported ($0.65) earnings per share for the quarter, missing analysts' consensus estimates of ($0.59) by $0.06. The business earned $8.38 billion during the quarter, compared to analysts' expectations of $6.55 million. Its quarterly revenue was up 95.0% on a year-over-year basis. Epizyme has generated ($1.93) earnings per share over the last year. Epizyme has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 3rd, 2021 based off prior year's report dates.

Epizyme Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Epizyme (NASDAQ:EPZM) Earnings Estimates

2021 EPS Consensus Estimate: ($2.55)
2022 EPS Consensus Estimate: ($2.11)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20213($0.68)($0.58)($0.64)
Q2 20213($0.68)($0.58)($0.64)
Q3 20213($0.68)($0.59)($0.64)
Q4 20213($0.68)($0.58)($0.63)
Q1 20221($0.59)($0.59)($0.59)
Q2 20221($0.56)($0.56)($0.56)
Q3 20221($0.49)($0.49)($0.49)
Q4 20221($0.47)($0.47)($0.47)

Epizyme (NASDAQ EPZM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/3/2021
(Estimated)
       
2/22/202112/31/2020($0.59)($0.65)($0.65)$6.55 million$8.38 billionTranscript
11/6/20209/30/2020($0.60)($0.55)($0.55)$5.89 million$3.60 millionTranscript
8/4/20206/30/2020($0.56)($0.58)($0.58)$4.67 million$2.47 millionTranscript
5/4/20203/31/2020($0.74)($0.51)($0.51)$2.63 million$1.35 millionTranscript
2/24/2020Q4 2019($0.51)($0.5932)($0.59)$2.83 million$4.29 millionTranscript
10/30/2019Q3 2019($0.5060)($0.3964)($0.40)$5.50 million$5.72 millionN/A
8/9/2019Q2 2019($0.51)($0.53)($0.53)$0.32 million$5.90 millionN/A
5/6/20193/31/2019($0.46)($0.39)($0.39)$1.13 million$7.89 millionN/A
2/26/2019Q4 2018($0.49)($0.29)($0.29)$11.50 million$9.70 millionN/A
11/2/20189/30/2018($0.61)($0.54)($0.54)$0.10 millionN/A
8/2/2018Q2 2018($0.53)($0.42)($0.42)$0.54 million$12.00 millionN/A
5/8/2018Q1 2018($0.54)($0.49)($0.49)$0.19 millionN/A
3/13/2018Q4 2017($0.57)($0.52)($0.52)$0.11 millionTranscript
11/1/2017Q3 2017($0.65)($0.63)($0.63)$0.19 millionN/A
8/4/2017Q2 2017($0.56)($0.48)($0.48)$3.95 million$10.00 millionN/A
5/8/2017Q1 2017($0.63)($0.56)($0.56)$0.49 millionN/A
3/9/2017Q4 2016($0.65)($0.60)($0.60)$0.61 million$0.48 millionListen
11/3/2016Q3($0.60)($0.42)($0.42)$0.57 million$6.58 millionListen
8/8/2016Q2($0.52)($0.49)($0.49)$0.61 million$0.47 millionListen
5/9/2016Q1($0.53)($0.41)($0.41)$0.58 million$0.47 millionListen
3/9/2016Q415($0.65)($0.53)($0.53)$0.66 million$0.56 millionListen
11/9/2015Q315($0.59)($0.56)($0.56)$8.75 million$0.36 millionListen
8/6/2015Q215($0.70)($0.63)($0.63)$2.23 million$0.74 millionListen
4/28/2015Q115($0.99)($1.75)($1.75)$6.48 million$0.91 millionN/A
3/12/2015Q414($0.54)($0.44)($0.44)$10.10 million$10.35 millionListen
11/6/2014Q314($0.54)($0.58)($0.58)$7.00 million$8.20 millionN/A
8/13/2014Q214($0.46)($0.40)($0.40)$7.59 million$9.50 millionN/A
5/13/2014Q114($0.48)($0.22)($0.22)$7.67 million$13.39 millionN/A
2/27/2014Q4 2013($0.37)$0.52$0.52$9.00 million$36.32 millionN/A
10/22/2013Q3 2013($0.36)($0.34)($0.34)$8.07 million$8.44 millionN/A
7/31/2013Q2 2013($0.26)($0.25)($0.25)$11.27 million$14.84 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.